On October 29, the Xiamen Science and Technology Bureau and Xiamen Cross-Strait Equity Exchange held an event introducing the Southwest Fujian Science and Technology Board and recognizing its first group of showcased companies.
The original notice described the board launch and plaque ceremony attended by representatives of the municipal science and financial authorities and Xiamen Jinyuan Group.
Thirty company representatives attended the ceremony, including Lifeint as a showcased company.
The historical notice described the Xiamen Cross-Strait Equity Exchange, established at the end of 2013, and reported that more than 100 companies had been showcased on the board at the time.
The notice described Lifeint’s research services, team, platelet RNA-sequencing and machine-learning research, and historical enterprise recognitions. It reported a first prize in the Xiamen division of the fifth China Innovation and Entrepreneurship Competition and expressed future research goals. These are historical statements; the notice does not establish present clinical performance.
Lifeint provides EV research and application services from sample preparation, isolation and characterization to omics, functional studies, modification and scale-up. It jointly established a biomedical technology centre with Xiamen University School of Pharmaceutical Sciences, built process-development laboratories to GMP standards, and contributed to an EV expert consensus. Its service records cover more than 300 plant species.
Scan to contact us on WeCom
